Next-gen Amulet 360 #LAAO showed favorable early outcomes in the VERITAS study. Both primary endpoints were met, and key clinical outcome rates were low. No leak was observed in 93.9% of patients on the 45-day TEE. https://bit.ly/4a1rS10
#JACCCEP #AFib #CardioSky #AFSymposium2026